Effects of dietary supplements on cognitive outcomes and physiological biomarkers in mild cognitive impairment: a systematic review and network meta-analysis
Abstract
Background: Mild cognitive impairment (MCI) represents a transitional stage between normal aging and dementia, affecting a significant proportion of the elderly population. Non-pharmacological nutritional supplements, such as vitamins, omega-3 fatty acids, probiotics, and herbal extracts, have been proposed as potential interventions to mitigate cognitive decline and improve physiological biomarkers. However, evidence on their efficacy remains inconsistent.
Objective: This systematic review and network meta-analysis (NMA) aimed to evaluate the effectiveness of various non-pharmacological nutritional supplements on cognitive function and key physiological indicators (e.g., BDNF, Aβ42, Aβ40) in elderly individuals with MCI.
Methods: This systematic review followed PRISMA-NMA guideline and was registered in PROSPERO (CRD420251079079). We searched PubMed, Embase, Cochrane Library, Web of Science, and CNKI databases from inception to June 2025 for randomized controlled trials (RCTs) comparing dietary supplements to placebo or no intervention. Data extraction included cognitive scores (e.g., MMSE, MoCA, FSIQ) and physiological markers. Risk of bias was assessed using the Cochrane Risk of Bias Tool. Pairwise meta-analyses and NMA were conducted using random-effects models, with standardized mean differences (SMD) for continuous outcomes. Heterogeneity was assessed via I 2 statistics, and sensitivity analyses were performed to test robustness.
Results: Thirteen trials involving…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 2,451 participants or records.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.